PIASy controls ubiquitination-dependent proteasomal degradation of Ets-1

Biochemical Journal

Volumn 405, Issue 3, 2007, Pages 481-488

  Nishida, Tamotsu ^a   Terashima, Motoko ^b   Fukami, Kiyoko ^b   Yamada, Yoshiji ^a  

^a MIE UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

E26 transformation specific 1 (Ets 1); Protein inhibitor of activated STAT (protein inhibitor of activated STAT) Y (PIASy); Small ubiquitin like modifier (SUMO); Ubiquitin (Ub)

Indexed keywords

E26 TRANSFORMATION-SPECIFIC-1 (ETS-1); PROTEIN INHIBITOR OF ACTIVATED STAT (PROTEIN INHIBITOR OF ACTIVATED STAT) Y (PIASY); SMALL UBIQUITIN-LIKE MODIFIER (SUMO); UBIQUITIN (UB);

DEGRADATION; PHOSPHORYLATION; PHYSIOLOGY; RNA;

PROTEINS;

LIGASE; PROTEASOME; PROTEIN INHIBITOR OF ACTIVATED STAT; SMALL INTERFERING RNA; SUMO PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS1; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CONTROLLED STUDY; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SUMOYLATION; TRANSCRIPTION REGULATION; UBIQUITINATION;

ANIMALS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; GENE EXPRESSION REGULATION; HUMANS; OSTEOSARCOMA; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTO-ONCOGENE PROTEIN C-ETS-1; UBIQUITINS;

EID: 34547458125     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20070026     Document Type: Article

References (26)

1. Graves, B. J. and Petersen, J. M. (1998) Specificity within the Ets family of transcription factors. Adv. Cancer Res. 75, 1-55
2. Seth, A., Ascione, R., Fisher, R. J., Mavrothalassitis, G. J., Bhat, N. K. and Papas, T. S. (1992) The Ets gene family. Cell Growth Differ. 3, 327-334
3. Janknecht, R. and Nordheim, A. (1993) Gene regulation by Ets proteins. Biochim. Biophys. Acta 1155, 346-356
4. Wasylyk, B., Hahn, S. L. and Giovane, A. (1993) The Ets family of transcription factors. Eur. J. Biochem. 211, 7-18
5. Sharrocks, A. D., Brown, A. L., Ling, Y. and Yates, P. R. (1997) The ETS-domain transcription factor family. Int. J. Biochem. Cell Biol. 29, 1371-1387
6. Span, P. N., Manders, P., Heuvel, J. J., Thomas, C. M., Bosch, R. R., Beex, L. V. and Sweep, C. G. (2002) Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer. Oncogene 21, 8506-8509
7. Buggy, Y., Maguire, T. M., McGreal, G., McDermott, E., Hill, A. D., O'Higgins, N. and Duffy, M. J. (2004) Overexpression of the Ets-1 transcription factor in human breast cancer. Br. J. Cancer, 91, 1308-1315
8. Katayama, S., Nakayama, T., Ito, M., Naito, S. and Sekine, I. (2005) Expression of the Ets-1 proto-oncogene in human breast carcinoma: differential expression with histological grading and growth pattern. Histol. Histopathol. 20, 119-126
9. Sementchenko, V. I. and Watson, D. K. (2000) Ets target genes: past, present and future. Oncogene 19, 6533-6548
10. Dittmer, J. (2003) The biology of the Ets1 proto-oncogene. Mol. Cancer 2, 29-49
11. Gill, G. (2004) SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev. 18, 2046-2059
12. Hay, R. T. (2005) SUMO: a history of modification. Mol. Cell 18, 1-12
13. Nishida, T., Terashima, M. and Fukami, K. (2006) PIASy-mediated repression of the Ets-1 is independent of its sumoylation. Biochem. Biophys. Res. Commun. 345, 1536-1546
14. Hershko, A. and Ciechanover, A. (1998) The ubiquitin system. Annu. Rev. Biochem. 67, 425-479
15. Lipford, J. R. and Deshaies, R. J. (2003) Diverse roles for ubiquitin-dependent proteolysis in transcriptional activation. Nat. Cell Biol. 5, 845-850
16. Muratani, M. and Tansey, W. P. (2003) How the ubiquitin-proteasome system controls transcription. Nat. Rev. Mol. Cell Biol. 4, 192-201
17. Nishida, T. and Yasuda, H. (2002) PIAS1 and PIASxα function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription. J. Biol. Chem. 277, 41311-41317
18. Vetter, M., Blumenthal, S. G., Lindemann, R. K., Manns, J., Wesselborg, S., Thomssen, C. and Dittmer, J. (2005) Ets-1 is an effector of protein kinase Cα in cancer cells. Oncogene 24, 650-661
19. Feikova, S., Wolff, L. and Bies, J. (2000) Constitutive ubiquitination and degradation of c-myb by the 26S proteasome during proliferation and differentiation of myeloid cells. Neoplasma 47, 212-218
20. Lin, H. K., Wang, L., Hu, Y. C., Altuwaijri, S. and Chang, C. (2002) Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J. 21, 4037-4048
21. Boulukos, K. E., Pognonec, P., Rabault, B., Begue, A. and Ghysdael, J. (1989) Definition of an Ets1 protein domain required for nuclear localization in cells and DNA-binding activity in vitro. Mol. Cell. Biol. 9, 5718-5721
22. Ji, Z., Degerny, C., Vintonenko, N., Deheuninck, J., Foveau, B., Leroy, C., Coll, J., Tulasne, D., Baert, J. L. and Fafeur, V. (2007) Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation. Oncogene 26, 395-406
23. Desterro, J. M., Rodriguez, M. S. and Hay, R. T. (1998) SUMO-1 modification of IκBα inhibits NF-κB activation. Mol. Cell 2, 233-239
24. Bies, J., Markus, J. and Wolff, L. (2002) Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity. J. Biol. Chem. 277, 8999-9009
25. Munarriz, E., Barcaroli, D., Stephanou, A., Townsend, P. A., Maisse, C., Terrinoni, A., Neale, M. H., Martin, S. J., Latchman, D. S., Knight, R. A. et al. (2004) PIAS-1 is a checkpoint regulator which affects exit from G1 and G2 by sumoylation of p73. Mol. Cell. Biol. 24, 10593-10610
26. Hattori, T., Eberspaecher, H., Lu, J., Zhang, R., Nishida, T., Kahyo, T., Yasuda, H. and de Crombrugghe, B. (2006) Interactions between PIAS proteins and SOX9 result in an increase in the cellular concentrations of SOX9. J. Biol. Chem. 281, 14417-14428